Riskpilot← Back to searchSign inGet full accessCurovis AB
ABActiveOrg 5567895783Stigbergsgatan 7Business and other management consultancy activities · NACE 7020Est. 20090 employees
Revenue 2024
SEK 117K
-37% vs 2023
EBITDA margin
-33.3%
-203% vs 2023
Equity ratio
99.5%
Financial strength
Net profit 2024
SEK 75K
+1597% vs 2023
| Revenue | SEK 117K | -37% |
| EBITDA | SEK -39K | -203% |
| Net profit | SEK 75K | +1597% |
| Total assets | SEK 11M | -1% |
| Equity | SEK 10,9M | -1% |
| Employees | 0 | — |
Legal name
Curovis AB
Org number
5567895783
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
23 september 2009
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Konsulting och utbildning inom affärsutveckling, verksamhetsutveckling, strategisk utveckling och ledarskap samt idrottsmassage för häst, samt övriga tjänster och produkter inom hästsport.
Address
Stigbergsgatan 7
Email
lars@curovis.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 202 | 27 | 18 | 187 | 117 |
| Staff expenses | — | — | — | — | −18 |
| EBITDA | −480 | −111 | −109 | 38 | −39 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | — |
| EBIT | −480 | −111 | −109 | 38 | −39 |
| Net financials | 827 | −51 | 73 | −290 | 114 |
| Profit before tax | 435 | 1 | 851 | −5 | 75 |
| Tax | −0 | −0 | −0 | −0 | — |
| Net profit | 435 | 1 | 851 | −5 | 75 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 11 381 | 10 590 | 11 256 | 11 090 | 10 957 |
| Equity | 10 754 | 10 571 | 11 234 | 11 034 | 10 905 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 627 | 19 | 22 | 56 | 52 |
| Total debt | 627 | 19 | 22 | 56 | 52 |
EBITDA margin
-33.3%
This company
15.8%
Market median
-311% vs market
20202024
Equity ratio
99.5%
This company
38.2%
Market median
+160% vs market
20202024
Return on equity
0.7%
This company
18.4%
Market median
-96% vs market
20202024
Net profit margin
64.0%
This company
8.1%
Market median
+690% vs market
20202024
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
LT Chief Executive Officer | Chief Executive Officer | 2022 |
EK Audit | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Curovis AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Thomas Bengtsson | Chief Executive Officer | 0 companies |
| Emma Karin Westholm | Audit | 0 companies |
| Jennie Maria Elenor Bengtsson | Board of Directors | 0 companies |
| Ingrid Maria Elenor Bengtsson | Chairman | 0 companies |
| Tim Lars Johan Lyckenvik | Board of Directors | 0 companies |